Trial Profile
The efficacy of swicthing from sulfonyl urea to the combination therapy with mitiglinide and voglibose on diurnal variation on glycemic control and endothelial function in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2016
Price :
$35
*
At a glance
- Drugs Mitiglinide (Primary) ; Voglibose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Jul 2016 Status changed from recruiting to completed.
- 14 Nov 2014 New trial record